- Brain cancer
- Brain metastases
- Brain tumor
- Central nervous system (CNS) cancer
Richard Edmund Phillips, MD, PhD
Medical Oncology, Neurology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
Penn Medicine Provider
About me
- Division Chief, Neuro-Oncology, Neurology
- Program Director, Neuro-Oncology Fellowship
- Presidential Assistant Professor of Neurology
- Assistant Professor of Neurology in Genetics
I am a neuro-oncologist who specializes in caring for people with primary brain tumors as well as neurologic complications of cancer (e.g. brain and leptomeningeal metastases, paraneoplasia, radiation necrosis). I am humbled by the opportunity to work with patients and their families during what can be a very vulnerable time. I have a special interest in the biology of brain tumors and direct a research lab where we discover new insights into these tumors such that more effective therapies can be developed.
My education and training
- Medical School: University of London
- Residency: Massachusetts General Hospital
- Fellowship: Memorial Sloan-Kettering Cancer Center
Spoken languages
English
English
Reviews
85 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Pennsylvania Hospital: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Qualifications and experience
- UCNS Neuro-Oncology, 2016
- American Academy of Cancer Research, National
- American Academy of Neurology, National
- American Brain Tumor Association, National
- American Society of Clinical Oncology, National
- National Institute of Health, National
- National Institutes of Health, National
- National Institutes of Health, National
- Society of Neuro-Oncology, International
- Penn Brain Tumor Center
- Penn Neuro-Oncology Program
Treatments and conditions
Research
Publications
Eimear Lagan, Dáire Gannon, Ademar Jesus Silva, Peter Bibawi, Anthony M Doherty, Darragh Nimmo, Rachel McCole, Craig Monger, Giovani Luiz Genesi, Aurelie Vanderlinden, James A Innes, Charlotte L E Jones, Lu Yang, Bryan Chen, Guido van Mierlo, Pascal W T C Jansen, Chinmayi Pednekar, Alexander Von Kriegsheim, Kieran Wynne, Francisco J Sánchez-Rivera, Yadira M Soto-Feliciano, Angel M Carcaboso, Michiel Vermeulen, Giorgio Oliviero, Chun-Wei Chen, Richard E Phillips*, Adrian P Bracken*, Gerard L Brien*. *=co-corresponding A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma , Molecular Cell , 85(11): 2025,2110-2127
Dáire Gannon, Eimear Lagan, Ademar Jesus Silva, Peter Bibawi, Anthony M. Doherty, Darragh Nimmo, Rachel McCole, Craig Monger, Giovani Genesi, Aurelie Vanderlinden Dibekeme, James A. Innes, Lu Yang, Bryan Chen, Guido van Mierlo, Pascal W.T.C Jansen, Keiran Wynne, Fran-cisco J. Sánchez-Rivera, Yadira M. Soto-Feliciano, Michiel Vermeulen, Giorgio Oliverio, Chun-Wei Chen, Richard E. Phillips, Adrian P. Bracken, Gerard L. Brien Specific cPRC1 complexes are co-opted to mediate oncogenic gene repression in diffuse midline glioma , Biorxiv: 2023
Liang R., Tomita D. Sasaki Y., Ginn J, Michino M., Huggins D., Baxt L., Kargman S., Shahid M., Kazuyoshi A., Duggan M., Stamford A., DeStanchina E., Liverton N., Meinke P., Foley M., Phillips R.E. A chemical strategy toward brain penetrant EZH2 inhibitors , ACS Medicinal Chemistry Letters, 13(3): 2022,377–387
Phillips RE, Soshnev AA, Allis CD. Epigenomic Reprogramming as a Driver of Malignant Glioma. , Cancer Cell, 38(5): 2020,647-660
Phillips, R. E., Yang, Y., Smith, R. C., Thompson, B. M., Yamasaki, T., SotoFeliciano, Y. M., Funato, K., Liang, Y., Garcia-Bermudez, J., Wang, X., Garcia, B. A., Yamasaki, K., McDonald, J. G., Birsoy, K., Tabar, V., & Allis, C. D. Target identification reveals lanosterol synthase as a vulnerability in glioma , Proceedings of the National Academy of Sciences of the United States of America, 116(16): 2019,7957–7962
Phillips, R. E., Curran, K. J., & Khakoo, Y Management of late extraneural recurrence of medulloblastoma without high-dose chemotherapy. , Journal of Neuro-Oncology, 124(3): 2015,523–524
Awosika, O. O., Lyons, J. L., Ciarlini, P., Phillips, R. E., Alfson, E. D., Johnson, E. L., Koo, S., Marty, F., Drew, C., Zaki, S., Folkerth, R. D., & Klein, J. P. Fatal adenovirus encephalomyeloradiculitis in an umbilical cord stem cell transplant recipient. , Neurology , 80(18): 2013,1715–1717
Bartel, G., Brown, K., Phillips, R., Peng, Q., Zhou, W., Sacks, S. H., & Wong, W. Donor specific transplant tolerance is dependent on complement receptors , Transplant International , 26(1): 2013,99-108
Wood, B. R., Klein, J. P., Lyons, J. L., Milner, D. A., Phillips, R. E., Schutten, M., Folkerth, R. D., Ciarlini, P., Henrich, T. J., & Johnson, J. A. HIV-2 encephalitis: Case report and literature review , AIDS Patient Care and STDs , 26 (7): 2012,383–387
Brown, K., Phillips, R. E., & Wong, W What have we learnt from experimental renal transplantation? , Nephron Experimental Nephrology, 115(1): 2010,e9-e14